Rezolute, Inc. (RZLT)
4.22
+0.05
(+1.20%)
USD |
NASDAQ |
Sep 11, 16:00
4.21
-0.01
(-0.24%)
After-Hours: 20:00
Rezolute Market Cap : 406.35M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 406.35M |
| September 10, 2026 | 401.54M |
| September 09, 2026 | 390.95M |
| September 08, 2026 | 423.69M |
| September 04, 2026 | 441.02M |
| September 03, 2026 | 437.17M |
| September 02, 2026 | 439.09M |
| September 01, 2026 | 433.32M |
| August 31, 2026 | 451.61M |
| August 28, 2026 | 444.87M |
| August 27, 2026 | 479.54M |
| August 26, 2026 | 485.31M |
| August 25, 2026 | 482.42M |
| August 24, 2026 | 482.42M |
| August 21, 2026 | 490.13M |
| August 20, 2026 | 448.72M |
| August 19, 2026 | 454.50M |
| August 18, 2026 | 448.72M |
| August 17, 2026 | 450.65M |
| August 14, 2026 | 442.94M |
| August 13, 2026 | 442.94M |
| August 12, 2026 | 452.57M |
| August 11, 2026 | 444.87M |
| August 10, 2026 | 450.65M |
| August 07, 2026 | 451.61M |
| Date | Value |
|---|---|
| August 06, 2026 | 452.57M |
| August 05, 2026 | 450.65M |
| August 04, 2026 | 478.57M |
| August 03, 2026 | 472.80M |
| July 31, 2026 | 454.50M |
| July 30, 2026 | 469.91M |
| July 29, 2026 | 452.57M |
| July 28, 2026 | 473.76M |
| July 27, 2026 | 475.68M |
| July 24, 2026 | 480.50M |
| July 23, 2026 | 511.31M |
| July 22, 2026 | 481.46M |
| July 21, 2026 | 490.13M |
| July 20, 2026 | 428.50M |
| July 17, 2026 | 443.91M |
| July 16, 2026 | 420.80M |
| July 15, 2026 | 456.43M |
| July 14, 2026 | 465.09M |
| July 13, 2026 | 456.43M |
| July 10, 2026 | 457.39M |
| July 09, 2026 | 493.98M |
| July 08, 2026 | 477.61M |
| July 07, 2026 | 478.57M |
| July 06, 2026 | 474.72M |
| July 02, 2026 | 472.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.331B |
| AbbVie, Inc. | 454.35B |
| Marker Therapeutics, Inc. | 19.17M |
| Avalo Therapeutics, Inc. | 852.76M |
| Krystal Biotech, Inc. | 10.27B |
Market Cap Related Metrics
| Price to Book Value | 3.478 |
| Price | 4.22 |
| Earnings Yield | -19.17% |